Company Profile

SYNGENE INTERNATIONAL LTD.

NSE : SYNGENEBSE : 539268ISIN CODE : INE398R01022Industry : MiscellaneousHouse : Private
BSE354.70-2.05 (-0.57 % )
PREV CLOSE (Rs.) 356.75
OPEN PRICE (Rs.) 362.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 10339
TODAY'S LOW / HIGH (Rs.)347.25 368.00
52 WK LOW / HIGH (Rs.)201.65 381.8
NSE352.20 -4.95 (-1.39 % )
PREV CLOSE(Rs.) 357.15
OPEN PRICE (Rs.) 360.70
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 352.20 (688 )
VOLUME 271574
TODAY'S LOW / HIGH(Rs.) 347.00 366.95
52 WK LOW / HIGH (Rs.)212.55 382

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.14
TTM EPS (Rs.) 10.29
P/E Ratio 34.48
Book Value (Rs.) 54.35
Face Value (Rs.) 10
MCap (Rs. in Mn) 141880.00
Price/Earning (TTM) 22.49
Price/Sales (TTM) 7.05
Price/Book (MRQ) 6.53
PAT Margin (%) 18.11
ROCE (%) 16.89
Incorporation Year : 1993

Management Info :

- Chairman Kiran Mazumdar Shaw - Managing Director

Registered Office :

Address : Biocon Sez, Biocon Park, No 2 & 3, Bommasandra,Industrail Area, Iv Pahse,Jigani Link Rd,
Bengaluru,
Karnataka-560099

Phone : 080 6775 5000

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
28Apr04-28-2020$Syngene International opens COVID-19 RT-PCR testing centre at Bengaluru site Syngene International opens

Syngene International has opened a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management, human clinical sample testing procedures, molecular biology and viral testing to gain the additional approvals, including ICMR approval, necessary to open the facility to support hospitals in the city.

A dedicated team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities. Necessary processes have been established for safe handling of the samples and testing kits have been sourced and validated. With the broad range of scientific expertise in relevant disciplines that Syngene offers, it is also working to supply reagents, primers and probes for COVID-19 diagnostic testing to clients, as well as working on research projects related to vaccine development which could represent a longer-term solution for fighting the coronavirus pandemic.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene International has opened a COVID-19 testing laboratory..
28Apr04-28-2020$Reliance Industries, Syngene International and Ambalal Sarabhai Enterprises to see some action today Reliance Industries, Syngene

Reliance Industries has allotted 27,950 Unsecured Redeemable Non-Convertible Debentures (NCDs) of the face value of Rs.10,00,000 each, aggregating Rs 2,795 crore (PPD Series L Debentures), issued on private placement basis.  The said NCDs are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Syngene International has opened a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management, human clinical sample testing procedures, molecular biology and viral testing to gain the additional approvals, including ICMR approval, necessary to open the facility to support hospitals in the city. A dedicated team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities. Necessary processes have been established for safe handling of the samples and testing kits have been sourced and validated.

CoSara is a joint venture company of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises and Co- Diagnostics Inc, USA, has been granted manufacturing license by Central Drugs Standard Control Organization (CDSO), Delhi to manufacture Saragenetm Covid-19, RT-PCR test kits in India. The company has started to manufacture the test kits based upon the license granted at its Gujarat based plant.

Coal India has signed two agreements with heavy engineering major BEML for purchasing dumpers at Rs 400 crore. The miner will procure 15 dumpers from the manufacturing PSU. The contract cost for seven 150-tonne dumpers is around Rs 150 crore and that of eight 190-tonne dumpers is Rs 250 crore.

Rallis India has resumed operations at its plants located at Lote, Ankleshwar and Dahej effective April 27, 2020 after completing critical maintenance jobs which could be taken up by advancing the Annual Shutdown. The production levels will be gradually increased. The company's operations come under the approved list of essential activities as per Ministry of Home Affairs, Government of India.

Dish TV India has entered into partnership with MX Player in a bid to offer unmatched video-on-demand content. With this strategic association with MX player, Dish TV India has further strengthened its portfolio by adding one more app in the app zone on its Android-based connected devices, namely Dish SMRT Hub and d2h stream for its DishTV and d2h users respectively. Users will now be able to stream an exciting slate of popular MX Originals, TV shows, Music Videos and Movies across multiple genres and languages.

Minda Industries has been granted approval to resume production at certain locations. Accordingly, production has resumed at certain facilities located in Pantnagar from April 24, 2020 at and Waluj from April 27, 2020. Clarton Horn’s manufacturing facility in Spain has also resumed production. These facilities are currently operating at partial capacity and production will be enhanced to normalized level in a phased manner, based on government directives and customer demand.

Reliance Industries has allotted 27,950 Unsecured Redeemable No..
28Apr04-28-2020$Syngene International shines on opening COVID-19 RT-PCR testing centre at Bengaluru site Syngene International shines

Syngene International is currently trading at Rs. 317.45, up by 7.90 points or 2.55% from its previous closing of Rs. 309.55 on the BSE.

The scrip opened at Rs. 320.00 and has touched a high and low of Rs. 320.00 and Rs. 315.00 respectively. So far 2330 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 368.10 on 14-Jun-2019 and a 52 week low of Rs. 201.65 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 332.95 and Rs. 305.10 respectively. The current market cap of the company is Rs. 12382.00 crore.

The promoters holding in the company stood at 70.70%, while Institutions and Non-Institutions held 22.92% and 6.37% respectively.

Syngene International has opened a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management, human clinical sample testing procedures, molecular biology and viral testing to gain the additional approvals, including ICMR approval, necessary to open the facility to support hospitals in the city.

A dedicated team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities. Necessary processes have been established for safe handling of the samples and testing kits have been sourced and validated. With the broad range of scientific expertise in relevant disciplines that Syngene offers, it is also working to supply reagents, primers and probes for COVID-19 diagnostic testing to clients, as well as working on research projects related to vaccine development which could represent a longer-term solution for fighting the coronavirus pandemic.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene International is currently trading at Rs. 317.45, up by..
20Mar03-20-2020$Syngene International commences operations at Mangalore manufacturing facility Syngene International commen

Syngene International has commenced operations at its newly setup manufacturing facility situated at Mangalore SEZ Unit - I, Kalavar Village, Post Mangaluru Taluk, Dakshina Kannada District, Karnataka. The company has successfully processed the first order upon receipt of all statutory licences and clearances from relevant authorities.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene International has commenced operations at its newly set..
20Mar03-20-2020$Alankit, Goa Carbon and Sobha to see some action today Alankit, Goa Carbon and Sobh

Alankit’s board has approved making investment by way of acquiring 100% stake in Alankit Imaginations ('Group Company') i.e. 14,00,000 Equity Shares of face value of Rs 10 each at a price of Rs 47.30 including premium of Rs 37.30 per share making it wholly owned subsidiary totaling investment of Rs 6.62 crore, subject to necessary approvals, if any.

Goa Carbon has resumed the operations at its Paradeep Unit located in Odisha. After preliminary heat up and commencement of feeding of raw material, normal production is likely to resume from March 20, 2020.

Sobha’s board has approved the issue of Secured Redeemable Non-Convertible Debentures up to an amount of Rs 270 crore by way of private placement. The Board of Directors of company at their meeting held on March 19, 2020 has approved the same.

DLF has unveiled state-of-the-art Club Ultima at New Gurugram. It is designed by the world-renowned Bilkey Llinas Designs, a company specializing in the design of high-end hospitality and leisure projects worldwide. The project located in DLF's flagship luxury project, The Ultima in sector 81 has the merit of being the largest and most well-appointed clubhouse of its kind in the region.

ICICI Lombard General Insurance Company has rolled out a focused 'COVID-19 Protection Cover'. The policy has been launched in group insurance mode. Amid the contagious pandemic, this policy on diagnosis of COVID-19 (+ve) will pay 100% of the sum insured irrespective of hospitalization expenses. The new product is a step forward in ICICI Lombard's endeavor in introducing industry-first initiatives for its customers in line with its ethos of ‘Nibhaaye Vaade’ (Keeping Promises).

Syngene International has commenced operations at its newly setup manufacturing facility situated at Mangalore SEZ Unit - I, Kalavar Village, Post Mangaluru Taluk, Dakshina Kannada District, Karnataka. The company has successfully processed the first order upon receipt of all statutory licences and clearances from relevant authorities.

InterGlobe Aviation (IndiGo) has reported the Passenger Load Factor (PLF) of 88.3% during the month of February 2020. The company had reported PLF of 87.8% during the month of January 2020.

Alankit’s board has approved making investment by way of acqu..
Financials More
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit12004115
Gross Profit 1526 5157
Operating Profit 22426983
Net Sales 607320119
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Quess Corp (BSE)
 201.60 (5.00%)
M.Cap ( in Cr)
2975.00
Just Dial (BSE)
 355.85 (2.36%)
M.Cap ( in Cr)
2309.60
Delta Corp (BSE)
 78.30 (4.96%)
M.Cap ( in Cr)
2121.45
BLS Internatl.Serv (BSE)
 31.25 (7.39%)
M.Cap ( in Cr)
320.16
Sagarsoft (India) (BSE)
 39.70 (4.47%)
M.Cap ( in Cr)
22.07
Shareholding Pattern More
MUTUAL FUNDS/UTI 8.2 %
PROMOTERS 70.69 %
NON-INSTITUTION 6.61 %
FI/BANKS/INSURANCE 0.05 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes